pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
News | Timely industry updates for pharma and biotech leaders
5 天之前 · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
The AI revolution in pharma | pharmaphorum
2 天之前 · The AI revolution in pharma and biotech is transforming the healthcare industry. Discover how artificial intelligence is revolutionising drug discovery, precision medicine, and patient care.
FDA approves flurry of drugs ahead of holiday season
2024年12月24日 · The FDA has followed its usual procedure of wrapping up a series of new drug approvals as the year draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
About pharmaphorum
2 天之前 · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com
pharmaphorum - The Deep Dive Digital Magazine has fresh …
2024年2月28日 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Generative AI in pharma: Moving beyond hype and into …
6 天之前 · Generative AI (GenAI) has rapidly pushed its way to the forefront of tech innovation. Its applications are seemingly limitless, and its rise has fuelled massive hype, speculation, and excitement.
Pharma and the ongoing battle against AI drift | pharmaphorum
3 天之前 · A study published in Nature, noted that it is less common for the input data to be monitored for data drift (systemic changes to input distributions) and found that monitoring performance alone is ...
Patients’ changing opinions of pharma - pharmaphorum
Respondents listed the industry’s achievements in R&D as the area where the most progress has been made in the last five years. It was the landslide winner, cited by 29% of those questioned, during a period which has seen the first gene therapies marketed, as …
Deep Dive | A bimonthly magazine for in-depth pharma stories
pharmaphorum presents a bimonthly Deep Dive magazine with extended, visually appealing features on R&D, patients, market access, digital health, and more.